Venture investment in biopharma and medtech has remained strong through the first quarter of 2024, as detailed in J.P. Morgan’s latest report, which utilizes data compiled by DealForma. Download the reports
Venture investment in biopharma and medtech has remained strong through the first quarter of 2024, as detailed in J.P. Morgan’s latest report, which utilizes data compiled by DealForma. Download the reports
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
